Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)


April 30, 2012
145 Pages - SKU: KLI3871497
License type:
Diagnostic Testing in the US Ancillary Hospital Locations (ER, OR, ICU)
5/29/2013 | published by: Venture Planning Group
This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth,  |  read more...
$12,500.00
2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs
6/4/2013 | published by: Venture Planning Group
This new 247-page report from Venture Planning Group provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report  |  read more...
$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Germany: Hospitals, Commercial Labs, Physician Offices
6/4/2013 | published by: Venture Planning Group
This new 249-page report from Venture Planning Group provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report  |  read more...
$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Italy: Hospitals and Commercial Labs
6/4/2013 | published by: Venture Planning Group
This new 247-page report from Venture Planning Group provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report  |  read more...
$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
6/4/2013 | published by: Venture Planning Group
This new 291-page report from Venture Planning Group provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report  |  read more...
$6,500.00
2013 Endocrine Function Testing Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers
6/6/2013 | published by: Venture Planning Group
This new 271-page report from Venture Planning Group provides a comprehensive analysis in the Spanish endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The  |  read more...
$2,450.00
2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices
6/7/2013 | published by: Venture Planning Group
This new 262-page report from Venture Planning Group provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The  |  read more...
$2,450.00
2013 Drugs of Abuse Testing in Italy: Hospitals and Commercial Labs
6/7/2013 | published by: Venture Planning Group
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the Italian drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The  |  read more...
$2,450.00
2013 Drugs of Abuse Testing in Japan: Hospitals and Commercial Labs
6/7/2013 | published by: Venture Planning Group
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The  |  read more...
$2,750.00
2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices
6/7/2013 | published by: Venture Planning Group
This new 262-page report from Venture Planning Group provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The  |  read more...
$3,500.00